Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evotec AG (EVO – Research Report), Shoulder Innovations, Inc. (SI – Research Report) and Bausch + Lomb Corporation (BLCO – Research Report).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Evotec AG (EVO)
In a report released today, Michael Ryskin from Bank of America Securities maintained a Sell rating on Evotec AG, with a price target of $3.00. The company’s shares closed last Tuesday at $2.67.
According to TipRanks.com, Ryskin is a 3-star analyst with an average return of
Evotec AG has an analyst consensus of Hold, with a price target consensus of $3.50.
See the top stocks recommended by analysts >>
Shoulder Innovations, Inc. (SI)
In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Shoulder Innovations, Inc., with a price target of $24.00. The company’s shares closed last Tuesday at $13.05.
According to TipRanks.com, Zimmerman is a 2-star analyst with an average return of
Shoulder Innovations, Inc. has an analyst consensus of Moderate Buy, with a price target consensus of $22.00.
Bausch + Lomb Corporation (BLCO)
Citi analyst Joanne Wuensch reiterated a Buy rating on Bausch + Lomb Corporation today and set a price target of $21.00. The company’s shares closed last Tuesday at $17.12.
According to TipRanks.com, Wuensch is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Bausch + Lomb Corporation with a $18.82 average price target, which is a 10.1% upside from current levels. In a report issued on March 3, Morgan Stanley also maintained a Buy rating on the stock with a $21.00 price target.
